Made Scientific Expands Leadership Team to Enhance Cell Therapy Manufacturing Capabilities

Made Scientific Expands Leadership Team



In a significant step towards enhancing its operational capacity, Made Scientific, a renowned contract development and manufacturing organization (CDMO) specializing in cell therapies, has augmented its Board of Directors. The appointments of Ted Dolan and Soyoung Park mark a strategic move designed to guide the company through its next phase of growth and scale-up.

Based in Princeton, New Jersey, Made Scientific has been on a substantial growth trajectory, reflecting the rising demand for advanced therapy developers. To support this momentum, the company has actively built a Board comprised of individuals with extensive experience in CDMO operations, financial management, and strategic planning. This newly formed leadership team brings a wealth of knowledge critical for navigating the complexities of late-phase and commercial manufacturing in the cell therapy sector.

Expanding the Board



The latest appointments enhance the Board's capabilities, allowing it to oversee the company's transition into more advanced manufacturing processes. Ted Dolan, with four decades of experience in the pharmaceutical manufacturing field, and Soyoung Park, known for her strategic insights in the bio-healthcare realm, bring essential expertise that will be pivotal as Made Scientific ramps up its operations.

Syed T. Husain, Chairman and CEO of Made Scientific, stated his commitment to constructing a Board that not only reflects deep industry knowledge but also aligns with the company’s long-term vision. With the addition of Dolan and Park, the team is poised to support the complexities of late-stage programs and enhance the company’s operational frameworks.

Strategic Direction



The decision to expand the Board is influenced by Made Scientific's ongoing efforts to increase its good manufacturing practice (GMP) capacity at its New Jersey facility. This move not only demonstrates the company’s ambition to meet the growing needs of its clients but also underscored the importance of scalable operations as projects approach commercial readiness. The ability to execute reliably is crucial in this phase, where operational discipline becomes synonymous with success.

Backed by GC Corporation, a steadfast strategic partner, Made Scientific is focused on building its operations deliberately — emphasizing quality and scale over immediate financial outcomes. This partnership reflects a mutual commitment to fostering long-term growth and maintaining a competitive edge within the cell therapy market.

Board Members' Expertise



Ted Dolan brings substantial operational leadership experience to the table, having previously served as COO at BioVectra and holding senior positions in prestigious companies like Alcami and Johnson Matthey. His background is fundamentally centered on scaling manufacturing organizations within complex therapeutic frameworks.

Soyoung Park, as the Managing Director of Strategy Planning at GC Corporation, strengthens the Board's strategic outlook. Her previous roles at IQVIA and A.T. Kearney position her to adeptly align Made Scientific’s strategies with global partners, ultimately enhancing the company’s market outreach.

The existing Board members such as Jin Pyun, Harry S. Rathore, Ph.D., and Yonghoon Kim further contribute a unique blend of executive insights from various sectors, ensuring a well-rounded governance approach.

Syed T. Husain emphasized the deliberate construction of the Board, targeting leaders capable of navigating complex environments, which is crucial as Made Scientific advances its initiatives in cell therapy manufacturing.

Conclusion



As Made Scientific integrates these pivotal board appointments, it remains focused on its mission to drive forward the capabilities in cell therapies, addressing both clinical and commercial manufacturing needs. This evolution not only positions the company as a leader in the CDMO space but also aligns it strategically to meet the challenges of an increasingly sophisticated healthcare landscape.

For additional information about Made Scientific and its operations, visit madescientific.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.